Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology

被引:0
|
作者
Aydogdu, G. [1 ]
Ozekinci, S. [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Pathol, Diyarbakir, Turkiye
关键词
Mesothelioma; immunohistochemistry; BAP1; FISH; MALIGNANT MESOTHELIOMA; HOMOZYGOUS DELETION; FISH; GENE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The cytological diagnosis of mesothelioma is a controversial is-sue, and definitive diagnosis often requires ancillary tests. The aim of this study was to investigate the contribution of BRCA1-associated protein (1) (BAP1) loss and p16 (CDKN2A) homozygous deletion (HD) on the early diagnosis of mesothelioma in effusion fluids. MATERIALS AND METHODS: Between 2019-2022, 21 pleural and peritoneal fluid samples di-agnosed with atypical mesothelial proliferation in our institution were included in the study. The slides of the cases that underwent BAP1 immu-nohistochemistry (IHC) were retrieved from the archive and re-examined. Homozygous deletion (HD) of p16 (CDKN2A) was investigated by the fluorescence in situ hybridization (FISH) method in cell blocks of cytology samples. At least 100 atypical mesothelial cells were counted in each case, and the HD threshold value was >10%. RESULTS: The mean age of the cases was 63.47 years (34-90 years), female/male ratio was 3/1. Of the pleural mesothelioma cases, 16 were epithelioid, 2 were biphasic, and 1 were sarco-matoid. Two cases were diagnosed with perito-neal well-differentiated papillary mesothelioma (WDPM). BAP1 loss was observed in 11 (69%) of 16 cases. HD deletion of p16 (CDKN2A) was seen in 11 (58%) patients with FISH. The HD threshold value was 10-20% in 6 of the cases, 30-50% in 3 cases, and above 90% in 2 cases. While HD de-letion was observed in p16 (CDKN2A) in all bi-phasic and sarcomatoid cases (n=3), no deletion was observed in peritoneal WDPM (n=2). Positiv-ity was observed with at least one method in 12 (86%) of 14 pleural mesotheliomas who under-went both BAP1 IHC and p16 (CDKN2A) FISH. Due to technical reasons, the FISH signal could not be obtained in two cell blocks, so no results could be obtained. CONCLUSIONS: Asbestos exposure in ar-eas where mesothelioma is endemic and/or the presence of proliferating mesothelial cells in cy-tological examination are important clues for diagnosis. In controversial cases, BAP1 IHC should be the first step in an ancillary test. Al-though the FISH method applied to cell blocks has cytology-specific limitations and difficul-ties, investigating the p16 (CDKN2A) deletion with FISH in selected cases will contribute to the diagnosis.
引用
收藏
页码:10001 / 10007
页数:7
相关论文
共 50 条
  • [41] BAP1 Immunostain and P16 FISH: Clinical Applicability to Confirm Malignant Mesothelioma in Effusions
    Walts, Ann E.
    Hiroshima, Kenzo
    McGregor, Stephanie
    Husain, Aliya N.
    Marchevsky, Alberto M.
    MODERN PATHOLOGY, 2016, 29 : 486A - 486A
  • [42] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas
    Tang, Vivian
    Lucas, Calixto-Hope
    Lu, Rufei
    Mirchia, Kanish
    Sullivan, Daniel
    Van Ziffle, Jessica
    Devine, Patrick
    Lee, Julieann
    Phillips, Joanna
    Perry, Arie
    Raleigh, David
    Solomon, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470
  • [43] BAP1 Immunostain and P16 FISH: Clinical Applicability to Confirm Malignant Mesothelioma in Effusions
    Walts, Ann E.
    Hiroshima, Kenzo
    McGregor, Stephanie
    Husain, Aliya N.
    Marchevsky, Alberto M.
    LABORATORY INVESTIGATION, 2016, 96 : 486A - 486A
  • [44] MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, Hanim I.
    Vinocha, Anjali
    Dono, Antonio
    Ogunbona, Oluwaseun Basit
    Toruner, Gokce A.
    Aung, Phyu P.
    Kamiya Matsuoka, Carlos
    Esquenazi, Yoshua
    Demonte, Franco
    Ballester, Leomar Y.
    CANCERS, 2024, 16 (19)
  • [45] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
  • [46] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Dacic, Sanja
    Kothmaier, Hannelore
    Land, Stephanie
    Shuai, Yongli
    Halbwedl, Iris
    Morbini, Patrizia
    Murer, Bruno
    Comin, Camilla
    Galateau-Salle, Francoise
    Demirag, Funda
    Zeren, Handan
    Attanoos, Richard
    Gibbs, Alan
    Cagle, Philip
    Popper, Helmut
    VIRCHOWS ARCHIV, 2008, 453 (06) : 627 - 635
  • [47] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Sanja Dacic
    Hannelore Kothmaier
    Stephanie Land
    Yongli Shuai
    Iris Halbwedl
    Patrizia Morbini
    Bruno Murer
    Camilla Comin
    Françoise Galateau-Salle
    Funda Demirag
    Handan Zeren
    Richard Attanoos
    Alan Gibbs
    Philip Cagle
    Helmut Popper
    Virchows Archiv, 2008, 453 : 627 - 635
  • [48] THE VALUE OF BAP1 IMMUNOCYTOCHEMISTRY AND CDKN2A FLUORESCENCE IN SITU HYBRIDIZATION IN DIAGNOSIS OF SEROUS EFFUSION MALIGNANT MESOTHELIOMA AND AN ANALYSIS OF THE ASSOCIATION BETWEEN DEGREE OF CELL ATYPIA AND THE RESULTS OF TWO AUXILIARY METHODS
    Ren, Wenhao
    Zhao, Lin-Lin
    Gu, Lei
    Lu, Ning
    Cao, Jian
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (03) : 229 - 235
  • [49] Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma
    Takita, J
    Hayashi, Y
    Kohno, T
    Yamaguchi, N
    Hanada, R
    Yamamoto, K
    Yokota, J
    CANCER RESEARCH, 1997, 57 (05) : 907 - 912
  • [50] EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index
    Purkait, Suvendu
    Sharma, Vikas
    Jha, Prerana
    Sharma, Mehar Chand
    Suri, Vaishali
    Suri, Ashish
    Sharma, B. S.
    Sarkar, Chitra
    NEUROPATHOLOGY, 2015, 35 (05) : 421 - 431